Butyric Acid

Butyric Acid

SCHEMBL4652533

CCCC(=O)O.CCCC(=O)O.CCCC(=O)O.CCCC(=O)O.CCCC(=O)O.CCCCCCCCCCCCCCCCOC(=O)CC(C)O.N

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.50
MAPT P10636 1/20 0.47
DGKA P23743 1/20 0.46
HTR2C P28335 1/20 0.45
RAD52 P43351 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
PPARG P37231 6/20 0.43
PPARD Q03181 6/20 0.43
PPARA Q07869 6/20 0.43
GPR84 Q9NQS5 5/20 0.43
HDAC11 Q96DB2 5/20 0.43
TSHR P16473 4/20 0.43
ALDH1A1 P00352 2/20 0.43
TLR2 O60603 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
FABP4 P15090 2/20 0.43
PTPN1 P18031 2/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
FAAH O00519 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5416562 0.89 NAAA (0.62) NAAAMAPTDGKAHTR2CRAD52
SCHEMBL28687231 0.89 NAAA (0.62) NAAAMAPTDGKAHTR2CRAD52
SCHEMBL5907685 0.89 NAAA (0.62) NAAAMAPTDGKAHTR2CRAD52
SCHEMBL5907657 0.89 NAAA (0.62) NAAAMAPTDGKAHTR2CRAD52
SCHEMBL28856166 0.89 NAAA (0.62) NAAAMAPTDGKAHTR2CRAD52
SCHEMBL5907614 0.89 NAAA (0.62) NAAAMAPTDGKAHTR2CRAD52
SCHEMBL5907696 0.89 NAAA (0.62) NAAAMAPTDGKAHTR2CRAD52
SCHEMBL28678097 0.89 NAAA (0.62) NAAAMAPTDGKAHTR2CRAD52
SCHEMBL5907628 0.89 NAAA (0.62) NAAAMAPTDGKAHTR2CRAD52
SCHEMBL5907659 0.89 NAAA (0.62) NAAAMAPTDGKAHTR2CRAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1602354-B1 Use of polyglutamic acid or its salts MEIJI SEIKA KAISHA (JP) 2008-11-05 EP disclosed
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair MEIJI SEIKA KAISHA, LTD. (JP) 2006-07-27 US disclosed
EP-1602354-A1 HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR Meiji Seika Kaisha, Ltd. (JP) 2005-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair CUTA, COL14A1, PRKDC NAAA 2723/4885MAPT 648/4885DGKA 315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.